Wang Xiaoyang Overall, respiratory infectious diseases this winter and spring still show a trend of alternating or overlapping epidemics, all caus by known pathogens, and no new infectious diseases emerg. It is expect that the overall epidemic intensity and mical pressure this year will not be higher than last year. Thanks!
CCTV reporter: Recently, respiratory diseases such mauritania email list 100000 contact leads as influenza have been prevalent, and the demand for micines among the public has increas significantly. What is the current overall production and supply situation of relevant drugs? In addition, what has the Ministry of Industry and Information Technology done to stabilize production and supply? Thanks.
The Ministry of Industry and Information Technology
Thank you for your question. my country is a major pharmaceutical industry country with 12,500 industrial enterprises above a certain scale. The industrial chain is resilient, with large production capacity and great potential for capacity expansion. It has the ability to rapidly increase production on a large scale, especially for drugs relat to corporate social responsibility at amazon respiratory diseases. It has a complete range of products and large production capacity and output to meet relevant nes. From the perspective of production and supply, the Ministry of Industry and Information Technology has systematically sort out the production capacity and output of respiratory diseaserelat drugs that are of concern to the public, including antipyretics and analgesics, antibiotics.
Traditional Chinese micine, small molecule antiviral drugs, etc
Overall, the supply is sufficient and the market is stable. For example, our daily production capacity of oseltamivir phosphate has reach 1.56 million doses, and our inventory exces 47 million doses, of which the inventory of granule dosage forms for children trust review exces 16 million doses; the daily production capacity of Lianhua Qingwen has reach 120 million tablets, and our inventory exces 86 million boxes; the daily production capacity of ibuprofen has reach 150 million tablets, and these categories have the ability to increase and expand production Wang Xiaoyang.
